Data-driven clustering identifies features distinguishing multisystem inflammatory syndrome from acute COVID-19 in children and adolescents.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Geva Alon, Patel Manish M, Newhams Margaret M, Young Cameron C, Son Mary Beth F, Kong Michele, Maddux Aline B, Hall Mark W, Riggs Becky J, Singh Aalok R, Giuliano John S, Hobbs Charlotte V, Loftis Laura L, McLaughlin Gwenn E, Schwartz Stephanie P, Schuster Jennifer E, Babbitt Christopher J, Halasa Natasha B, Gertz Shira J, Doymaz Sule, Hume Janet R, Bradford Tamara T, Irby Katherine, Carroll Christopher L, McGuire John K, Tarquinio Keiko M, Rowan Courtney M, Mack Elizabeth H, Cvijanovich Natalie Z, Fitzgerald Julie C, Spinella Philip C, Staat Mary A, Clouser Katharine N, Soma Vijaya L, Dapul Heda, Maamari Mia, Bowens Cindy, Havlin Kevin M, Mourani Peter M, Heidemann Sabrina M, Horwitz Steven M, Feldstein Leora R, Tenforde Mark W, Newburger Jane W, Mandl Kenneth D, Randolph Adrienne G, Overcoming COVID-19 Investigators
Аннотация
METHODS: We performed unsupervised clustering on data from 1,526 patients (684 labeled MIS-C by clinicians) <21 years old hospitalized with COVID-19-related illness admitted between 15 March 2020 and 31 December 2020. We compared prevalence of assigned MIS-C labels and clinical features among clusters, followed by recursive feature elimination to identify characteristics of potentially misclassified MIS-C-labeled patients.
FINDINGS: Of 94 clinical features tested, 46 were retained for clustering. Cluster 1 patients (N = 498; 92% labeled MIS-C) were mostly previously healthy (71%), with mean age 7·2 ± 0·4 years, predominant cardiovascular (77%) and/or mucocutaneous (82%) involvement, high inflammatory biomarkers, and mostly SARS-CoV-2 PCR negative (60%). Cluster 2 patients (N = 445; 27% labeled MIS-C) frequently had pre-existing conditions (79%, with 39% respiratory), were similarly 7·4 ± 2·1 years old, and commonly had chest radiograph infiltrates (79%) and positive PCR testing (90%). Cluster 3 patients (N = 583; 19% labeled MIS-C) were younger (2·8 ± 2·0 y), PCR positive (86%), with less inflammation. Radiographic findings of pulmonary infiltrates and positive SARS-CoV-2 PCR accurately distinguished cluster 2 MIS-C labeled patients from cluster 1 patients.
INTERPRETATION: Using a data driven, unsupervised approach, we identified features that cluster patients into a group with high likelihood of having MIS-C. Other features identified a cluster of patients more likely to have acute severe COVID-19 pulmonary disease, and patients in this cluster labeled by clinicians as MIS-C may be misclassified. These data driven phenotypes may help refine the diagnosis of MIS-C.